EMORY INTEGRATED GENOMICS SHARED RESOURCE PROJECT SUMMARY/ ABSTRACT The Emory Integrated Genomics Core Shared Resource (Genomics SR; Categories 1.16, 1.21, and 1.35) provides services allowing scientists to conduct deep genomic sequencing, probe gene expression and methylation patterns in a tissue sample, or search for mutations in an individual's DNA or in a tumor. The central mission of this facility as a Winship shared resource is to support the research efforts of Winship members by providing exceptional cancer genomics services Genomics SR provides services in research and CLIA settings which include nucleic acid extraction, Illumina sequencing, high-density microarray services on both the Affymetrix and Illumina platforms, targeted enrichment, and single nucleotide polymorphism (SNP) genotyping. Significant improvements in shared resource organization and efficiency have increased capacity, lowered costs, and increased service offerings. Service offerings for Illumina next generation sequencing (NGS) have dramatically increased after the adoption of a broker model in which all large-scale service requests are competitively outsourced to one of several academic or commercial vendors. New services, including microbiome and single cell services, have been launched for Winship members. Genomics SR has maintained its CLIA license (CLIA: 11D1086150) and developed closer ties with the Emory Genetics Laboratory, which is now offering clinical cancer diagnostic testing. Improved access to computational resources through the Emory Integrated Computational Core (EICC) and increased collaboration with Winship's Biostatistics and Bioinformatics Shared Resource (BBISR) have significantly enhanced the analysis of large-scale genomics data sets by Winship members. As a consequence of these changes, usage by Winship members have significantly increased during the current funding period. Genomics SR currently provides valuable services in support of Winship discovery and is well positioned to adopt novel genomic services which will advance Winship research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA138292-10
Application #
9480799
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
10
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Cassidy, Richard J; Zhang, Xinyan; Switchenko, Jeffrey M et al. (2018) Health care disparities among octogenarians and nonagenarians with stage III lung cancer. Cancer 124:775-784
Xiao, Canhua; Beitler, Jonathan J; Higgins, Kristin A et al. (2018) Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer. Brain Behav Immun 74:291-295
Jhaveri, Jaymin; Rayfield, Lael; Liu, Yuan et al. (2018) Impact of intensity modulated radiation therapy on survival in anal cancer. J Gastrointest Oncol 9:618-630
Jhaveri, Jaymin; Chowdhary, Mudit; Zhang, Xinyan et al. (2018) Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases. J Neurosurg :1-7
Chowdhary, Mudit; Switchenko, Jeffrey M; Press, Robert H et al. (2018) Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery. J Neurooncol 139:689-697
Bilen, Mehmet Asim; Dutcher, Giselle Marie Almeida; Liu, Yuan et al. (2018) Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab. Clin Genitourin Cancer 16:e563-e575
Morgan, T M; Wang, X; Qian, X et al. (2018) Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes. Clin Transl Oncol :
Lin, Songbai; Han, Yiran; Jenkin, Kayte et al. (2018) Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis. Am J Pathol 188:353-366
Zhu, Dan; Osuka, Satoru; Zhang, Zhaobin et al. (2018) BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. Cancer Cell 33:1004-1016.e5
Bekhbat, Mandakh; Chu, Karen; Le, Ngoc-Anh et al. (2018) Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression. Psychoneuroendocrinology 98:222-229

Showing the most recent 10 out of 331 publications